Aura Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Aura Biosciences

27/03/2024 13:23

* Aura Biosciences Inc  AURA.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -55 cents.  The mean expectation of five analysts for the
quarter was for a loss of 41 cents per share. Wall Street
expected results to range from -44 cents to -39 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aura Biosciences Inc's reported EPS for the quarter was a
loss
of 56 cents​.
    * The company reported a quarterly loss of $22.13 million.
    * Aura Biosciences Inc shares had fallen by 13.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aura Biosciences
Inc is $20.00 
This summary was machine generated from LSEG data March 27 at
01:23 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.41          -0.56          Missed
 Sep. 30 2023      -0.52          -0.48          Beat
 Jun. 30 2023      -0.49          -0.48          Beat
 Mar. 31 2023      -0.54          -0.46          Beat